Company Analysis Healthcare Trust, Inc.
1. Summary
Advantages
- The stock's return over the last year (398.37%) is higher than the sector average (-37.81%).
Disadvantages
- Price (9.2 $) is higher than fair price (8.73 $)
- Dividends (0%) are below the sector average (6.03%).
- Current debt level 59.07% has increased over 5 years from 48.93%.
- The company's current efficiency (ROE=-24.03%) is lower than the sector average (ROE=3.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Healthcare Trust, Inc. | Real Estate | Index | |
|---|---|---|---|
| 7 days | 0% | -40.1% | -0.6% |
| 90 days | 10.8% | -37.1% | 5.7% |
| 1 year | 398.4% | -37.8% | 9% |
HLTC vs Sector: Healthcare Trust, Inc. has outperformed the "Real Estate" sector by 436.19% over the past year.
HLTC vs Market: Healthcare Trust, Inc. has outperformed the market by 389.4% over the past year.
Stable price: HLTC is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HLTC with weekly volatility of 7.66% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (9.2 $) is higher than the fair price (8.73 $).
Price is higher than fair: The current price (9.2 $) is 5.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (26.95).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (59.87).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.3288) is lower than that of the sector as a whole (0.9905).
P/BV vs Market: The company's P/BV (0.3288) is lower than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.6413) is lower than that of the sector as a whole (4.84).
P/S vs Market: The company's P/S indicator (0.6413) is lower than that of the market as a whole (3.43).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-37.13) is lower than that of the sector as a whole (125.34).
EV/Ebitda vs Market: The company's EV/Ebitda (-37.13) is lower than that of the market as a whole (40.12).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 30.25% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (30.25%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-11.18%).
5.4. ROE
ROE vs Sector: The company's ROE (-24.03%) is lower than that of the sector as a whole (3.61%).
ROE vs Market: The company's ROE (-24.03%) is lower than that of the market as a whole (41.73%).
5.5. ROA
ROA vs Sector: The company's ROA (-9.27%) is lower than that of the sector as a whole (1.6%).
ROA vs Market: The company's ROA (-9.27%) is lower than that of the market as a whole (29.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (4.91%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.99%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '6.03%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
